AAAAAA
Results: 1-25/112
Authors:
Bytzer, P
Talley, NJ
Citation: P. Bytzer et Nj. Talley, Current indications for acid suppressants in dyspepsia, BEST PR RES, 15(3), 2001, pp. 385-400
Authors:
Bensoussan, A
Chang, SW
Menzies, RG
Talley, NJ
Citation: A. Bensoussan et al., Application of the general health status questionnaire SF36 to patients with gastrointestinal dysfunction: initial validation and validation as a measure of change, AUS NZ J PU, 25(1), 2001, pp. 71-77
Authors:
Talley, NJ
Citation: Nj. Talley, Drug therapy options for patients with irritable bowel syndrome, AM J M CARE, 7(8), 2001, pp. S261-S267
Authors:
Deng, J
Jones, R
Kahrilas, P
Talley, NJ
Citation: J. Deng et al., Management of gastro-oesophageal reflux disease in general practice, BR MED J, 322(7282), 2001, pp. 344-347
Authors:
Talley, NJ
Phung, N
Kalantar, JS
Citation: Nj. Talley et al., ABC of the upper gastrointestinal tract - Indigestion: When is it functional?, BR MED J, 323(7324), 2001, pp. 1294-1297
Authors:
Talley, NJ
Citation: Nj. Talley, Dealing with patients' concerns and expectations, EUR J GASTR, 13, 2001, pp. S5-S6
Authors:
Talley, NJ
Citation: Nj. Talley, Should oesophagitis be healed?, EUR J GASTR, 13, 2001, pp. S36-S37
Authors:
Talley, NJ
Citation: Nj. Talley, Efficacies of different proton pump inhibitors in reflux disease, EUR J GASTR, 13, 2001, pp. S55-S57
Authors:
Talley, NJ
Citation: Nj. Talley, When and why should empirically treated patients have endoscopy?, EUR J GASTR, 13, 2001, pp. S74-S76
Authors:
Koloski, NA
Talley, NJ
Boyce, PM
Morris-Yates, AD
Citation: Na. Koloski et al., The effects of questionnaire length and lottery ticket inducement on the response rate in mail surveys, PSYCHOL HEA, 16(1), 2001, pp. 67-75
Authors:
Shaw, MJ
Beebe, TJ
Adlis, SA
Talley, NJ
Citation: Mj. Shaw et al., Reliability and validity of the digestive health status instrument in samples of community, primary care, and gastroenterology patients, ALIM PHARM, 15(7), 2001, pp. 981-987
Authors:
Talley, NJ
Van Zanten, SV
Saez, LR
Dukes, G
Perschy, T
Heath, M
Kleoudis, C
Mangel, AW
Citation: Nj. Talley et al., A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia, ALIM PHARM, 15(4), 2001, pp. 525-537
Authors:
Talley, NJ
Lauritsen, K
Tunturi-Hihnala, H
Lind, T
Moum, B
Bang, C
Schulz, T
Omland, TM
Delle, M
Junghard, O
Citation: Nj. Talley et al., Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6months, ALIM PHARM, 15(3), 2001, pp. 347-354
Authors:
Talley, NJ
Verlinden, M
Jones, M
Citation: Nj. Talley et al., Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form, ALIM PHARM, 15(2), 2001, pp. 207-216
Authors:
Talley, NJ
Riff, DS
Schwartz, H
Marcuard, SP
Citation: Nj. Talley et al., Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection, ALIM PHARM, 15(10), 2001, pp. 1603-1611
Authors:
Bytzer, P
Talley, NJ
Jones, MP
Horowitz, M
Citation: P. Bytzer et al., Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus, ALIM PHARM, 15(1), 2001, pp. 137-142
Authors:
Hammer, J
Talley, NJ
Citation: J. Hammer et Nj. Talley, Nonulcer dyspepsia, CURR OPIN G, 17(6), 2001, pp. 518-522
Authors:
Talley, NJ
Citation: Nj. Talley, Therapeutic options in nonulcer dyspepsia, J CLIN GAST, 32(4), 2001, pp. 286-293
Authors:
Holtmann, G
Gschossmann, J
Holtmann, M
Talley, NJ
Citation: G. Holtmann et al., H-pylori and functional dyspepsia - Increased serum antibodies as an independent risk factor?, DIG DIS SCI, 46(7), 2001, pp. 1550-1557
Authors:
Talley, NJ
Citation: Nj. Talley, Serotoninergic neuroenteric modulators, LANCET, 358(9298), 2001, pp. 2061-2068
Authors:
Mearin, F
Badia, X
Balboa, A
Baro, E
Caldwell, E
Cucala, M
Diaz-Rubio, M
Fueyo, A
Ponce, J
Roset, M
Talley, NJ
Citation: F. Mearin et al., Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: Comparison of Rome II versus previous criteria in a general population, SC J GASTR, 36(11), 2001, pp. 1155-1161
Authors:
Talley, NJ
Eslick, GD
Citation: Nj. Talley et Gd. Eslick, Non-cardiac chest pain - Reply, MED J AUST, 174(9), 2001, pp. 483-483
Authors:
Talley, NJ
Citation: Nj. Talley, H pylori and functional dyspepsia, GUT, 49(5), 2001, pp. 738-739
Authors:
Talley, NJ
Verlinden, M
Geenen, DJ
Hogan, RB
Riff, D
McCallum, RW
Mack, RJ
Citation: Nj. Talley et al., Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial, GUT, 49(3), 2001, pp. 395-401
Authors:
Bytzer, P
Howell, S
Leemon, M
Young, LJ
Jones, MP
Talley, NJ
Citation: P. Bytzer et al., Low socioeconomic class is a risk factor for upper and lower gastrointestinal symptoms: a population based study in 15,000 Australian adults, GUT, 49(1), 2001, pp. 66-72